glp-1 receptor agonists effects on cardiovascular risk reduction of in Heart Failure Patients A clinician's perspective 📝 GLP-1

For patients, these cost saving measures can feel frustrating and counterproductive

Cosmetic and hair changes with GLP-1s While you might think GLP-1s only lead to positive changes to your appearance, there is the potential for unexpected negative side effects that could affect how you look

Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality and renal outcomes in patients with diabetes and albuminuria: a systematic review and meta-analysis

We also lack evidence that they extend lifespan in otherwise healthy people

Zepbound is FDA-approved for chronic weight management and may offer enhanced results for patients struggling with obesity or weight-related health concerns

Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial